After soaring on Tuesday, ALT stock is trading down nearly 10% on Wednesday. Yesterday’s results came after Altimmune Inc. (NASDAQ:ALT) announced positive Phase 2 results for its flu vaccine candidate.
ALT Stock TodayOn March 19th, Altimmune Inc., which is a clinical-stage immunotherapeutics company, reported positive results for its Phase 2 trial. According to the company, all of the evaluated subjects in its study were seroprotected from infection for over a year after they were initially vaccinated.
Addressing the results, the CEO of Altimmune Inc., Vipin K. Garg, said the following: “We are excited ...
Read The Full Article On MicroSmallCap.com
Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.